Consultation Document Draft Report Project Number HT0038-000 Call for feedback jeu 07/03/2024 - 00:01 Feedback Due By jeu 21/03/2024 - 23:59 Project Line Health Technology Review Webform Node Alemtuzumab, Cladribine, Fingolimod, and Natalizumab as First-Line Treatments in Adult Patients With Highly Active Relapsing Multiple Sclerosis - Draft Science Report - HT0038 Message d'état Désolé... Ce formulaire est clos aux nouvelles soumissions.
Alemtuzumab, Cladribine, Fingolimod, and Natalizumab as First-Line Treatments in Adult Patients With Highly Active Relapsing Multiple Sclerosis - Draft Science Report - HT0038 Message d'état Désolé... Ce formulaire est clos aux nouvelles soumissions.